Skye Bioscience, Inc. Common Stock Cash Flow-to-Debt Ratio
Skye Bioscience, Inc. Common Stock cash flow-to-debt ratio. Skye Bioscience, Inc. Common Stock (SKYE) has a Cash Flow-to-Debt Ratio of -0.62x as of June 2026, meaning its operating cash flow of $-7.12 Million could theoretically repay -1% of its total liabilities ($11.53 Million) in one year. Check how high is Skye Bioscience, Inc. Common Stock's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Skye Bioscience, Inc. Common Stock (2012–2025)
Cash flow-to-debt ratio of Skye Bioscience, Inc. Common Stock from 2012 to 2025. Historical debt coverage capacity for Skye Bioscience, Inc. Common Stock across 14 annual periods. Check SKYE capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Skye Bioscience, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2012–2025)
Skye Bioscience, Inc. Common Stock cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Skye Bioscience, Inc. Common Stock. For the full cash flow conversion analysis, see Skye Bioscience, Inc. Common Stock operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -5.19x | $-43.06 Million | $8.29 Million | ▲ +5.1% |
| 2024 | -5.47x | $-25.24 Million | $4.61 Million | ▼ -451.9% |
| 2023 | -0.99x | $-13.95 Million | $14.07 Million | ▲ +5.7% |
| 2022 | -1.05x | $-12.74 Million | $12.12 Million | ▲ +35.2% |
| 2021 | -1.62x | $-6.47 Million | $3.99 Million | ▲ +40.5% |
| 2020 | -2.73x | $-6.05 Million | $2.22 Million | ▲ +34.5% |
| 2019 | -4.16x | $-6.03 Million | $1.45 Million | ▼ -1748.8% |
| 2018 | -0.23x | $-3.94 Million | $17.52 Million | ▲ +90.7% |
| 2017 | -2.43x | $-3.30 Million | $1.36 Million | ▼ -21.3% |
| 2016 | -2.00x | $-3.55 Million | $1.77 Million | ▼ -63.3% |
| 2015 | -1.23x | $-3.73 Million | $3.04 Million | ▲ +44.0% |
| 2014 | -2.19x | $-1.76 Million | $801.89K | ▼ -2650.6% |
| 2013 | -0.08x | $-14.49K | $182.15K | ▼ -117.9% |
| 2012 | 0.45x | $1.93K | $4.33K | — |